Clinical trials in Janki

Clinical trials focusing on meningococcal infection prevention through vaccination studies in healthy infants and toddlers, evaluating protective antibody responses against multiple bacterial serogroups.

• Vaccine Immunogenicity
• Pediatric Vaccination
• Preventive Medicine

Research aims to assess the effectiveness of a novel conjugate vaccine targeting meningococcal serogroups A, C, W, and Y in young children, with special attention to safety and immune response measurements.

Investigation of a new vaccination schedule for infants at 6-7 months and toddlers at 12-13 months, comparing innovative vaccine formulations with established products.

• Infant Health
• Vaccination Safety
• Age-Specific Response

The study emphasizes the development of protective immunity during critical early childhood periods through a carefully designed two-dose vaccination series.

Comprehensive evaluation of a meningococcal vaccine designed to protect against multiple bacterial strains, focusing on establishing non-inferior immune responses compared to existing vaccines.

• Public Health
• Disease Prevention
• Vaccine Development

This research contributes to advancing preventive strategies against serious bacterial infections in vulnerable young populations.